Waqar Ahmed

Nephrology
8836 State Route 434
Apalachin, NY 13732

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Proteomic identification and validation of novel neuronal EV-based markers for Alzheimer's disease biomarker discovery.

Proteomic identification and validation of novel neuronal EV-based markers for Alzheimer's disease biomarker discovery.

Journal: bioRxiv : the preprint server for biology
Published: May 07, 2026

Proteomic profiling of brain organoids and extracellular vesicles identifies early Alzheimer's disease biomarkers and drug response heterogeneity.

Proteomic profiling of brain organoids and extracellular vesicles identifies early Alzheimer's disease biomarkers and drug response heterogeneity.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: November 26, 2025

Mapping key mitochondrial genes in Alzheimer's disease through human tissue and iPSC derived neurons.

Mapping key mitochondrial genes in Alzheimer's disease through human tissue and iPSC derived neurons.

Journal: Scientific reports
Published: June 05, 2025

Detection of High-grade Bladder Cancer in Urine Samples Using In Situ Hybridization of Long Noncoding RNA UCA1.

Detection of High-grade Bladder Cancer in Urine Samples Using In Situ Hybridization of Long Noncoding RNA UCA1.

Journal: Urology
Published: February 19, 2025

New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines.

New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines.

Journal: MedChemComm
Published: June 23, 2018

Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.

Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.

Journal: European journal of medicinal chemistry
Published: January 26, 2017
Showing 1-6 of 6

Last Updated: 09/26/2026